Higher Highs Coming!Today's AGM will be a very positive meeting, and I can imagine that those in attendance will be celebrating with champagne. Cheers and a toast to ICO managment for successfully passing phase one trials. This issue of non-toxicity I mentioned yesterday is indeed a very big issue when it comes to the adoption of Oral B Amphotericin which is likely to replace the injectable dose which is a product owned by Gilead. Could Gilead be in talks with ICO on moving the company forward to phase two trials on a joint collaboration?
Or is AstraZeneca ICO's sweetheart partner?
So, ICO is now the most beautiful girl at the dance, and can choose who to partner with.
May I have this dance?
Hold on tight to your shares and your dreams because ICO is going to make a series of higher highs on the strength of it's drug development pipeline. Congratulations to longs.
DOC.